U.S.–China Hantavirus Collaboration and Oversight

🧵Hantavirus an Anthony Fauci Gain-of-Function Frankenstein gone wrong?

Public records show U.S.–China overlap in hantavirus clinical treatment research, surveillance, molecular epidemiology, phylogenetics, reservoir-host research, and natural reassortment/pathogenicity studies. https://t.co/8F0QTJdKt3

2/ Hantavirus U.S.–China overlap isn’t one visible “joint GOF program.”

Public record points to cooperation in treatment trials, surveillance, molecular epidemiology, host-jump ecology, reassortment analysis, and countermeasures. (1) https://t.co/gClDgENmya

3/ The clearest direct overlap:

USAMRIID worked with scientists/physicians in Wuhan in the 1980s on a randomized, double-blind ribavirin trial for HFRS/Hantaan disease.

A 2023 history calls it a formal USAMRIID–Chinese govt collaboration. (2) https://t.co/g004ywXRoP

4/ China matters because HFRS has been a huge domestic burden:

CDC EID review reported 1,557,622 HFRS cases and 46,427 deaths in China from 1950–2007, across 29 of 31 provinces. (3) https://t.co/9zGajAsqwx

5/ Academic overlap shows up in Chinese CDC + U.S. university authorship.

A 2010 CDC EID review lists China’s State Key Lab/CDC authors alongside University of Georgia’s Zhen F. Fu. (4) https://t.co/e2hCKR6wuc

6/ The research focus:

Rodents, reservoirs, and transmission ecology—especially Hantaan virus in Apodemus mice and Seoul virus in Rattus rats.

That’s surveillance/ecology, not proof of engineering. (3) https://t.co/471QnkyFap

7/ Another overlap:

Molecular diversity and phylogeny. A Guizhou Hantaan virus paper lists Chinese CDC, Guizhou CDC, Beijing hospital, University of Georgia, and Helsinki affiliations. (5) https://t.co/4hlNkZKK8q

8/ This is where “GOF-adjacent” language appears:

Spillover, host range, reassortment, and pathogenicity.

Public papers frame key examples as natural reassortment/cross-species evolution—not engineered enhancement. (5)(6) https://t.co/J8hVrVtiKE

9/ A 2013 PLOS Pathogens study

Bats, shrews, rodents, and hantavirus origins included Chinese CDC/state lab affiliations plus an NIH/Fogarty-linked author.

It reported four novel hantavirus sequences from animals collected in China. (6) https://t.co/47k5M2gMsH

10/ That PLOS study found virus and host trees often don’t match

This suggests cross-species transmission helped shape hantavirus evolution.

That’s a legitimate zoonotic-emergence question—and a dual-use watch zone. (6) https://t.co/3JfcIAb7T0

11/ Countermeasures are the other overlap.

U.S. vaccine papers cite China’s licensed inactivated HFRS vaccines and China’s burden, while U.S. groups pursue DNA vaccine approaches for Hantaan/Puumala viruses. (7) https://t.co/LThe6m8lwd

12/ Summary: the overlap is real in clinical trials, surveillance, coauthorship, phylogeny, host-jump ecology, natural reassortment, and countermeasures.

But public sources do not prove a modern U.S.–China engineered hantavirus GOF program. (1-7) https://t.co/lwq9PyVH9I

13/ Footnotes:

1. https://t.co/sFltIYWSca

2. https://t.co/UKJKr7dhGJ

3. https://t.co/A4tef40u8Q

4. https://t.co/0NS6ilJTqu

5.https://t.co/ngFwXLOLC5

6. https://t.co/vRFbzEtiyT

7. https://t.co/Qms7YvI15y

8. https://t.co/noJ2zMz4eM

@threadreaderapp unroll please